Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

(Bloomberg) -- Bristol Myers Squibb Co. raised its 2024 earnings guidance after reporting better-than-expected revenue and ...